Webinar Registration



Is Alzheimer’s Disease Preventable and Reversible? New Functional Medicine Approach Webinar


Among the various concerns regarding the aging body, cognitive decline remains one of the most distressing. Losing cognitive function takes away many integral aspects of life as making decisions can become extremely difficult or impossible. The prevalence of cognitive decline is increasing along with the growing fear. Dementia was estimated to affect nearly 130 million people worldwide in 2015. In recent years we have seen growing evidence that a multifaceted approach can postpone the development of and potentially reverse the progression of Alzheimer’s disease in some cases. For example, the work of Dr. Dale Bredesen shows promising results with the implementation of a carefully regimented lifestyle protocol termed Reversing Cognitive Decline (ReCODE) therapy. In this one hour presentation Dr Kogan will review the best existing evidence for integrative approaches for Alzheimer's disease prevention and treatment.

We hope you can join us live on September 21st at 3 p.m. PT. If not, don’t worry, signing up will still grant you access to the webinar recording.


2022-09-21 15:00:00
Pacific Time
Misha_headshot_WEB_02 copy-1

Mikhail Kogan, MD

Dr. Kogan received his medical degree from Drexel University, College of Medicine.  He completed Social Internal Medicine Resident program at Montefiore, Albert Einstein School of Medicine and Geriatric Fellowship at George Washington University.  Currently he serves as medical director of the GW Center for Integrative Medicine, associate professor of medicine in division of Geriatrics and Palliative Care, associate director of the Geriatrics Fellowship Program and director of Integrative Medicine Track program at the George Washington University School of Medicine.   

Dr. Kogan is founder and executive director of AIM Health Institute, a 501(c)(3) non-profit organization in the Washington, D.C. metropolitan area that provides integrative medicine services to low-income and terminally ill patients regardless of their ability to pay.